HEADER PROTEIN BINDING 14-JUN-18 6GSE TITLE SOLUTION STRUCTURE OF THE CAPSID DOMAIN FROM THE ACTIVITY-REGULATED TITLE 2 CYTOSKELETON-ASSOCIATED PROTEIN, ARC COMPND MOL_ID: 1; COMPND 2 MOLECULE: ACTIVITY-REGULATED CYTOSKELETON-ASSOCIATED PROTEIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ACTIVITY-REGULATED GENE 3.1 PROTEIN,ARG3.1; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 3 ORGANISM_COMMON: NORWAY RAT; SOURCE 4 ORGANISM_TAXID: 10116; SOURCE 5 GENE: ARC; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS RETROVIRAL CAPSID DOMAIN, NMDA RECEPTOR INTERACTION, GAG PROTEIN, KEYWDS 2 PROTEIN BINDING EXPDTA SOLUTION NMR; SOLUTION SCATTERING NUMMDL 20 AUTHOR L.D.NIELSEN,S.ERLENDSSON,K.TEILUM REVDAT 4 14-JUN-23 6GSE 1 REMARK REVDAT 3 21-AUG-19 6GSE 1 REMARK REVDAT 2 10-JUL-19 6GSE 1 JRNL REVDAT 1 22-MAY-19 6GSE 0 JRNL AUTH L.D.NIELSEN,C.P.PEDERSEN,S.ERLENDSSON,K.TEILUM JRNL TITL THE CAPSID DOMAIN OF ARC CHANGES ITS OLIGOMERIZATION JRNL TITL 2 PROPENSITY THROUGH DIRECT INTERACTION WITH THE NMDA JRNL TITL 3 RECEPTOR. JRNL REF STRUCTURE V. 27 1071 2019 JRNL REFN ISSN 0969-2126 JRNL PMID 31080121 JRNL DOI 10.1016/J.STR.2019.04.001 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : XPLOR-NIH REMARK 3 AUTHORS : SCHWIETERS, KUSZEWSKI, TJANDRA AND CLORE REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6GSE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 14-JUN-18. REMARK 100 THE DEPOSITION ID IS D_1200009908. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 7.4 REMARK 210 IONIC STRENGTH : 50 REMARK 210 PRESSURE : 1 BAR REMARK 210 SAMPLE CONTENTS : 0.5 MM [U-15N] ARC, 90% H2O/10% REMARK 210 D2O; 1 MM [U-13C; U-15N] ARC, 90% REMARK 210 H2O/10% D2O; 0.5 MM [U-15N] ARC, REMARK 210 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 3D HNCA; 3D REMARK 210 HN(CO)CA; 3D HNCO; 3D HN(CA)CO; REMARK 210 3D CBCA(CO)NH; 3D HNCACB; 3D 1H- REMARK 210 15N TOCSY; 3D HCCH-TOCSY; 3D 1H- REMARK 210 15N NOESY; 3D 1H-13C NOESY; 3D REMARK 210 1H-13C TOCSY AROMATIC REMARK 210 SPECTROMETER FIELD STRENGTH : 750 MHZ; 800 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE III; DD2 REMARK 210 SPECTROMETER MANUFACTURER : BRUKER; AGILENT REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CYANA, CCPNMR ANALYSIS REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 80 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 265 REMARK 265 EXPERIMENTAL DETAILS REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11450 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 THR A 211 70.60 47.17 REMARK 500 1 PHE A 214 -35.43 -159.85 REMARK 500 1 SER A 280 -53.29 -120.96 REMARK 500 1 GLN A 361 95.22 59.90 REMARK 500 2 LEU A 209 -156.63 48.57 REMARK 500 2 THR A 211 80.96 46.19 REMARK 500 2 GLN A 212 40.58 37.25 REMARK 500 2 PHE A 214 107.14 58.10 REMARK 500 2 GLU A 215 97.71 -49.62 REMARK 500 2 SER A 280 -63.97 -123.86 REMARK 500 2 ARG A 338 -35.63 -152.62 REMARK 500 3 LEU A 209 -177.56 -58.71 REMARK 500 3 ALA A 316 -176.41 -57.38 REMARK 500 3 ALA A 362 100.14 -171.84 REMARK 500 4 GLN A 212 36.06 -87.24 REMARK 500 4 ASN A 247 88.15 -156.82 REMARK 500 4 SER A 280 -66.02 -124.83 REMARK 500 4 ALA A 316 -172.31 -59.10 REMARK 500 4 LYS A 332 4.19 -69.80 REMARK 500 4 PRO A 340 150.67 -48.21 REMARK 500 4 ALA A 362 27.13 49.30 REMARK 500 5 LEU A 209 72.69 52.69 REMARK 500 5 SER A 280 -54.46 -120.63 REMARK 500 6 ASP A 210 31.38 -159.48 REMARK 500 7 ASP A 210 91.92 -62.35 REMARK 500 7 THR A 211 -37.96 171.24 REMARK 500 7 ILE A 213 -99.53 53.03 REMARK 500 7 PHE A 214 -74.70 -144.70 REMARK 500 7 SER A 280 -66.77 -125.24 REMARK 500 7 LEU A 359 13.41 53.96 REMARK 500 7 ALA A 362 37.55 38.48 REMARK 500 8 THR A 211 35.70 -143.60 REMARK 500 8 GLN A 212 -57.97 -170.34 REMARK 500 8 ILE A 213 48.68 -74.21 REMARK 500 8 GLN A 361 179.93 54.11 REMARK 500 8 ALA A 362 -67.61 -90.39 REMARK 500 9 LYS A 262 -19.92 -141.16 REMARK 500 9 LEU A 359 -35.02 171.21 REMARK 500 10 ASP A 210 69.20 61.81 REMARK 500 10 THR A 211 67.26 34.51 REMARK 500 10 GLU A 215 40.72 -158.31 REMARK 500 10 SER A 280 -56.04 -128.57 REMARK 500 10 GLN A 330 149.54 -39.08 REMARK 500 10 GLN A 361 159.98 59.98 REMARK 500 11 THR A 211 25.52 -141.75 REMARK 500 11 ASN A 263 -167.04 -170.10 REMARK 500 11 PRO A 331 -8.26 -59.17 REMARK 500 11 GLU A 360 -67.20 70.68 REMARK 500 12 LEU A 209 91.14 -61.04 REMARK 500 12 THR A 211 -34.94 -163.96 REMARK 500 REMARK 500 THIS ENTRY HAS 98 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 34285 RELATED DB: BMRB REMARK 900 SOLUTION STRUCTURE OF THE CAPSID DOMAIN FROM THE ACTIVITY-REGULATED REMARK 900 CYTOSKELETON-ASSOCIATED PROTEIN, ARC DBREF 6GSE A 206 364 UNP Q63053 ARC_RAT 206 364 SEQADV 6GSE LEU A 209 UNP Q63053 VAL 209 CONFLICT SEQRES 1 A 159 SER PRO GLY LEU ASP THR GLN ILE PHE GLU ASP PRO ARG SEQRES 2 A 159 GLU PHE LEU SER HIS LEU GLU GLU TYR LEU ARG GLN VAL SEQRES 3 A 159 GLY GLY SER GLU GLU TYR TRP LEU SER GLN ILE GLN ASN SEQRES 4 A 159 HIS MET ASN GLY PRO ALA LYS LYS TRP TRP GLU PHE LYS SEQRES 5 A 159 GLN GLY SER VAL LYS ASN TRP VAL GLU PHE LYS LYS GLU SEQRES 6 A 159 PHE LEU GLN TYR SER GLU GLY THR LEU SER ARG GLU ALA SEQRES 7 A 159 ILE GLN ARG GLU LEU ASP LEU PRO GLN LYS GLN GLY GLU SEQRES 8 A 159 PRO LEU ASP GLN PHE LEU TRP ARG LYS ARG ASP LEU TYR SEQRES 9 A 159 GLN THR LEU TYR VAL ASP ALA GLU GLU GLU GLU ILE ILE SEQRES 10 A 159 GLN TYR VAL VAL GLY THR LEU GLN PRO LYS PHE LYS ARG SEQRES 11 A 159 PHE LEU ARG HIS PRO LEU PRO LYS THR LEU GLU GLN LEU SEQRES 12 A 159 ILE GLN ARG GLY MET GLU VAL GLN ASP GLY LEU GLU GLN SEQRES 13 A 159 ALA ALA GLU HELIX 1 AA1 ASP A 210 GLU A 215 1 6 HELIX 2 AA2 PRO A 217 GLY A 232 1 16 HELIX 3 AA3 SER A 234 MET A 246 1 13 HELIX 4 AA4 GLY A 248 GLN A 258 1 11 HELIX 5 AA5 ASN A 263 ASP A 289 1 27 HELIX 6 AA6 PRO A 297 TYR A 313 1 17 HELIX 7 AA7 GLU A 317 VAL A 326 1 10 HELIX 8 AA8 GLY A 327 LEU A 329 5 3 HELIX 9 AA9 GLN A 330 PHE A 336 1 7 HELIX 10 AB1 THR A 344 GLN A 361 1 18 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1